HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
333.00
-2.11 (-0.63%)
At close: Nov 20, 2024, 4:00 PM
330.00
-3.00 (-0.90%)
Pre-market: Nov 21, 2024, 4:51 AM EST
HCA Healthcare Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for HCA Healthcare stock have an average target of 374.06, with a low estimate of 265 and a high estimate of 440. The average target predicts an increase of 12.33% from the current stock price of 333.00.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HCA Healthcare stock from 17 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 6 | 4 | 3 |
| Buy | 8 | 7 | 6 | 6 | 7 | 8 |
| Hold | 5 | 5 | 5 | 6 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 17 | 17 | 18 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $396 → $392 | Buy | Maintains | $396 → $392 | +17.72% | Nov 8, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $395 → $400 | Hold | Maintains | $395 → $400 | +20.12% | Nov 6, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $450 → $440 | Strong Buy | Maintains | $450 → $440 | +32.13% | Oct 28, 2024 |
| Keybanc | Keybanc | Buy Maintains $475 → $420 | Buy | Maintains | $475 → $420 | +26.13% | Oct 28, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $390 → $400 | Buy | Maintains | $390 → $400 | +20.12% | Oct 28, 2024 |
Financial Forecast
Revenue This Year
71.31B
from 64.97B
Increased by 9.76%
Revenue Next Year
75.68B
from 71.31B
Increased by 6.13%
EPS This Year
22.17
from 18.97
Increased by 16.89%
EPS Next Year
24.87
from 22.17
Increased by 12.14%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 75.2B | 81.2B | 84.8B | ||
| Avg | 71.3B | 75.7B | 79.5B | ||
| Low | 68.8B | 72.3B | 75.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 15.7% | 13.9% | 12.0% | ||
| Avg | 9.8% | 6.1% | 5.0% | ||
| Low | 6.0% | 1.4% | 0.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 24.09 | 26.79 | 30.36 | ||
| Avg | 22.17 | 24.87 | 27.60 | ||
| Low | 21.17 | 23.26 | 24.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 27.0% | 20.8% | 22.1% | ||
| Avg | 16.9% | 12.1% | 11.0% | ||
| Low | 11.6% | 4.9% | -2.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.